Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SUPV3L1 | Human | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SUPV3L1 mRNA | CTD | PMID:25075043 | SUPV3L1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Supv3l1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA | CTD | PMID:36331819 | SUPV3L1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SUPV3L1 mRNA | CTD | PMID:21215274 | SUPV3L1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Supv3l1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SUPV3L1 mRNA | CTD | PMID:21570461 | SUPV3L1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of SUPV3L1 mRNA | CTD | PMID:21346803 | SUPV3L1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of SUPV3L1 mRNA | CTD | PMID:21346803 | SUPV3L1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA | CTD | PMID:28628672 | SUPV3L1 | Human | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of SUPV3L1 mRNA | CTD | PMID:17039268 | SUPV3L1 | Human | acrylamide | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of SUPV3L1 mRNA | CTD | PMID:28959563 | SUPV3L1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SUPV3L1 mRNA | CTD | PMID:33167477 | SUPV3L1 | Human | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SUPV3L1 mRNA | CTD | PMID:25075043 | SUPV3L1 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SUPV3L1 mRNA | CTD | PMID:22378314 | SUPV3L1 | Human | atrazine | affects methylation | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of SUPV3L1 gene | CTD | PMID:28931070 | SUPV3L1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SUPV3L1 mRNA | CTD | PMID:20678512 | SUPV3L1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SUPV3L1 protein | CTD | PMID:34186270 | SUPV3L1 | Human | bisphenol A | decreases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SUPV3L1 mRNA | CTD | PMID:30816183 and PMID:32528016 | SUPV3L1 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA | CTD | PMID:28628672 | SUPV3L1 | Human | bisphenol A | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SUPV3L1 mRNA | CTD | PMID:25181051 | SUPV3L1 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of SUPV3L1 protein | CTD | PMID:34186270 | SUPV3L1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of SUPV3L1 protein | CTD | PMID:34186270 | SUPV3L1 | Human | carbon nanotube | increases expression | ISO | Supv3l1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | SUPV3L1 | Human | cisplatin | increases phosphorylation | ISO | Supv3l1 (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of SUPV3L1 protein | CTD | PMID:22006019 | SUPV3L1 | Human | cobalt dichloride | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of SUPV3L1 mRNA | CTD | PMID:24386269 | SUPV3L1 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SUPV3L1 mRNA | CTD | PMID:19549813 | SUPV3L1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SUPV3L1 mRNA | CTD | PMID:20106945 and PMID:25562108 | SUPV3L1 | Human | deguelin | increases expression | EXP | | 6480464 | deguelin results in increased expression of SUPV3L1 mRNA | CTD | PMID:33512557 | SUPV3L1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA | CTD | PMID:28628672 | SUPV3L1 | Human | doxorubicin | decreases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Doxorubicin results in decreased expression of SUPV3L1 mRNA | CTD | PMID:19915844 | SUPV3L1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SUPV3L1 mRNA | CTD | PMID:29803840 | SUPV3L1 | Human | fenthion | decreases expression | ISO | Supv3l1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of SUPV3L1 mRNA | CTD | PMID:34813904 | SUPV3L1 | Human | finasteride | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of SUPV3L1 mRNA | CTD | PMID:24136188 | SUPV3L1 | Human | flutamide | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of SUPV3L1 mRNA | CTD | PMID:24136188 | SUPV3L1 | Human | folic acid | decreases expression | ISO | Supv3l1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SUPV3L1 mRNA | CTD | PMID:25629700 | SUPV3L1 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SUPV3L1 protein | CTD | PMID:37730182 | SUPV3L1 | Human | gentamycin | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of SUPV3L1 mRNA | CTD | PMID:33387578 | SUPV3L1 | Human | glyphosate | increases methylation | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Glyphosate results in increased methylation of SUPV3L1 gene | CTD | PMID:31011160 | SUPV3L1 | Human | hydrogen peroxide | decreases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | Hydrogen Peroxide results in decreased expression of SUPV3L1 protein | CTD | PMID:23178681 | SUPV3L1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA | CTD | PMID:28628672 | SUPV3L1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SUPV3L1 protein | CTD | PMID:32959892 | SUPV3L1 | Human | methidathion | decreases expression | ISO | Supv3l1 (Mus musculus) | 6480464 | methidathion results in decreased expression of SUPV3L1 mRNA | CTD | PMID:34813904 | SUPV3L1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SUPV3L1 mRNA | CTD | PMID:25704631 | SUPV3L1 | Human | pentachlorophenol | increases expression | ISO | Supv3l1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of SUPV3L1 mRNA | CTD | PMID:23892564 | SUPV3L1 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SUPV3L1 mRNA | CTD | PMID:32588087 | SUPV3L1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Supv3l1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA | CTD | PMID:36331819 | SUPV3L1 | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of SUPV3L1 mRNA | CTD | PMID:19159669 | SUPV3L1 | Human | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of SUPV3L1 mRNA | CTD | PMID:33512557 | SUPV3L1 | Human | pirinixic acid | increases expression | ISO | Supv3l1 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of SUPV3L1 mRNA | CTD | PMID:19162173 | SUPV3L1 | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SUPV3L1 mRNA | CTD | PMID:33512557 | SUPV3L1 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of SUPV3L1 mRNA | CTD | PMID:25895662 | SUPV3L1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SUPV3L1 mRNA | CTD | PMID:25979313 | |